Journal
MOLECULAR PHARMACOLOGY
Volume 62, Issue 2, Pages 389-397Publisher
AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
DOI: 10.1124/mol.62.2.389
Keywords
-
Categories
Funding
- NIA NIH HHS [AG18200] Funding Source: Medline
- PHS HHS [AL59598] Funding Source: Medline
Ask authors/readers for more resources
Brain histamine H-3 receptors are predominantly presynaptic and serve an important autoregulatory function for the release of histamine and other neurotransmitters. They have been implicated in a variety of brain functions, including arousal, locomotor activity, thermoregulation, food intake, and memory. The recent cloning of the H-3 receptor in our laboratory has made it possible to create a transgenic line of mice devoid of H-3 receptors. This paper provides the first description of the H-3 receptor-deficient mouse (H-3(-/-)), including molecular and pharmacologic verification of the receptor deletion as well as phenotypic screens. The H-3(-/-) mice showed a decrease in overall locomotion, wheel-running behavior, and body temperature during the dark phase but maintained normal circadian rhythmicity. H-3(-/-) mice were insensitive to the wake-promoting effects of the H-3 receptor antagonist thioperamide. We also observed a slightly decreased stereotypic response to the dopamine releaser, methamphetamine, and an insensitivity to the amnesic effects of the cholinergic receptor antagonist, scopolamine. These data indicate that the H-3 receptor-deficient mouse represents a valuable model for studying histaminergic regulation of a variety of behaviors and neurotransmitter systems, including dopamine and acetylcholine.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available